# Efficacy of glucagon‐like peptide‐1 receptor agonists compared to dipeptidyl peptidase‐4 inhibitors for the management of type 2 diabetes: A meta‐analysis of randomized clinical trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-glucagon-like-peptide-1-receptor-agonists-compared-to-dipeptidyl/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Susan T. Tran,Ravi Retnakaran,Bernard Zinman,Caroline K. Kramer |
| Citations | 51 |
| DOI | 10.1111/dom.13137 |
| Fields | Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2791740462 |
| PMID | 29364587 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Susan T. Tran](https://scholariq.org/researchers/susan-t-tran/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Neuropeptides and Animal Physiology](https://scholariq.org/topics/neuropeptides-and-animal-physiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.